GHIT Fund Global Health Innovative Technology Fund

Featured News

November 16, 2021PRESS

The Pediatric Praziquantel Consortium Announces Positive Phase III Results fo…

February 16, 2021NEWS

Scientific article archive launch

December 11, 2017TOOLS

Strategic Plan 2018-2022

Annual Report 2020

GHIT's 2020 Annual Report is now available. The report highlights GHIT and our partners' progress and updates in FY2020: invested partnerships from discovery to clinical candidates, our portfolio, strategic plan progress, other highlighted activities, and a financial summary.

Press ReleaseArchive

November 16, 2021

The Pediatric Praziquantel Consortium Announces Positive Phase III Results fo…
November 4, 2021

GHIT Fund Announces New Investments: A Total of 750 Million Yen in Drugs for …
July 15, 2021

GHIT Fund Announces New Investment: 97.4 Million Yen to Identify Novel Dual-A…

NewsArchive

November 2, 2021

New investment opportunity for Product Development Platform
November 2, 2021

New investment opportunity for Target Research Platform
September 10, 2021

Announcing New Board Member Dr. Richard Seabrook

EventsArchive

November 25, 2021 Upcoming

Completion of its pivotal Phase III trial of arpraziquantel – a potenti…
October 28, 2021 Past Event

[Session 3] JAGntd-GHIT NTD webinar series: Challenges of expanding access to…
October 27, 2021 Past Event

[Session 3] GHIT Fund - Product Development Partnerships (PDPs) Webinar Serie…

PublicationsArchive

June 24, 2021 GHIT Report

GHIT’s 2020 Annual Report Published
June 30, 2020 GHIT Report

GHIT’s 2019 Annual Report Published
June 3, 2019 GHIT Report

GHIT’s 2018 Annual Report Published

FilmsArchive

Film: GHIT Fund Proposal Writing Seminar (English ver / at GHIT R&D Forum)

Film: GHIT Fund Proposal Writing Seminar (Japanese Language Only)

GHIT Brand Film

ToolsArchive

GHIT Fund Leaflet

Strategic Plan 2018-2022

5th Anniversary Website